Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristen M Marks

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Current HIV/AIDS Reports|February 20, 2025
Update on Vaccination Recommendations for Adults with HIVFiona Gispen, Kristen M Marks
Antiviral Therapy|November 29, 2012
The first wave: HCV NS3 protease inhibitors telaprevir and boceprevirKristen M Marks, Ira M Jacobson
Annals of Internal Medicine|October 9, 2023
COVID-19Kristen M Marks, Roy M Gulick
Clinical Therapeutics|July 10, 2018
Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care ProvidersShashi N Kapadia, Kristen M Marks
Nature Clinical Practice. Gastroenterology & Hepatology|July 9, 2008
How effective is eltrombopag for the treatment of thrombocytopenia in patients with HCV infection?James B Bussel, Kristen M Marks
Current Opinion in HIV and AIDS|December 7, 2025
Hepatitis B virus vaccination in people with HIV: what's new?Fiona Gispen, Anne F Luetkemeyer, Kristen M Marks
Best Practice & Research. Clinical Rheumatology|August 21, 2019
Management of hepatitis B and C infections in rheumatologic diseaseJonathan Tl Cheah, John J Faragon, Kristen M Marks
JAMA|June 30, 2026
Antiviral Therapies for Adults With Mild to Moderate COVID-19 InfectionPeggy B Leung, Andrew M Davis, Kristen M Marks
Vaccine|March 27, 2025
An efficient vaccine clinical trial: ACTG A5379 hepatitis B vaccine trial in persons with HIVMinhee Kang, Kristen M Marks, Andrea L Cox, et al.
Gastroenterology & Hepatology|March 3, 2023
Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World ExamplesAne-Kristine Finbråten, Benjamin J Eckhardt, Shashi N Kapadia, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Current HIV/AIDS Reports|February 20, 2025
Update on Vaccination Recommendations for Adults with HIVFiona Gispen, Kristen M Marks
Antiviral Therapy|November 29, 2012
The first wave: HCV NS3 protease inhibitors telaprevir and boceprevirKristen M Marks, Ira M Jacobson
Annals of Internal Medicine|October 9, 2023
COVID-19Kristen M Marks, Roy M Gulick
Clinical Therapeutics|July 10, 2018
Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care ProvidersShashi N Kapadia, Kristen M Marks
Nature Clinical Practice. Gastroenterology & Hepatology|July 9, 2008
How effective is eltrombopag for the treatment of thrombocytopenia in patients with HCV infection?James B Bussel, Kristen M Marks
Current Opinion in HIV and AIDS|December 7, 2025
Hepatitis B virus vaccination in people with HIV: what's new?Fiona Gispen, Anne F Luetkemeyer, Kristen M Marks
Best Practice & Research. Clinical Rheumatology|August 21, 2019
Management of hepatitis B and C infections in rheumatologic diseaseJonathan Tl Cheah, John J Faragon, Kristen M Marks
JAMA|June 30, 2026
Antiviral Therapies for Adults With Mild to Moderate COVID-19 InfectionPeggy B Leung, Andrew M Davis, Kristen M Marks
Vaccine|March 27, 2025
An efficient vaccine clinical trial: ACTG A5379 hepatitis B vaccine trial in persons with HIVMinhee Kang, Kristen M Marks, Andrea L Cox, et al.
Gastroenterology & Hepatology|March 3, 2023
Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World ExamplesAne-Kristine Finbråten, Benjamin J Eckhardt, Shashi N Kapadia, et al.
Pageof 4